Cite
DU J, Guo Y, Bao Y, et al. Anticancer activities of sulindac in prostate cancer cells associated with c-Jun NH2-terminal kinase 1/β-catenin signaling. Oncol Lett. 2014;8(1):313-316doi: 10.3892/ol.2014.2084.
DU, J., Guo, Y., Bao, Y., Xing, M., Mahmoud, A. M., Che, Z., Chen, Z., & Yang, W. (2014). Anticancer activities of sulindac in prostate cancer cells associated with c-Jun NH2-terminal kinase 1/β-catenin signaling. Oncology letters, 8(1), 313-316. https://doi.org/10.3892/ol.2014.2084
DU, Jun, et al. "Anticancer activities of sulindac in prostate cancer cells associated with c-Jun NH2-terminal kinase 1/β-catenin signaling." Oncology letters vol. 8,1 (2014): 313-316. doi: https://doi.org/10.3892/ol.2014.2084
DU J, Guo Y, Bao Y, Xing M, Mahmoud AM, Che Z, Chen Z, Yang W. Anticancer activities of sulindac in prostate cancer cells associated with c-Jun NH2-terminal kinase 1/β-catenin signaling. Oncol Lett. 2014 Jul;8(1):313-316. doi: 10.3892/ol.2014.2084. Epub 2014 Apr 25. PMID: 24959268; PMCID: PMC4063579.
Copy
Download .nbib